• 1. Isotruxene-based porous polymers as efficient and recyclable photocatalysts for visible-light induced metal-free oxidative organic transformations
  Haowen Zhang,Cen Zhou,Ying Zheng,Xiao Zhang Green Chem. 2021 23 8878
• 2. Interfacial restructuration of carbon nitride polymers for visible-light photocatalysis
  Feng Lin,Zihao Yu,Xinchen Wang Chem. Commun. 2019 55 8235
• 3. Nitrogen–boron coordination versus OH?N hydrogen bonding in pyridoxaboroles – aza analogues of benzoxaboroles
  I. Steciuk,K. Durka,K. Gontarczyk,M. D?browski,S. Luliński,K. Wo?niak Dalton Trans. 2015 44 16534

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Recent Advances in the Application of Boronic acid,1,2-phenylenebis- (9CI) (CAS: 13506-83-7) in Chemical Biology and Pharmaceutical Research

Boronic acid,1,2-phenylenebis- (9CI) (CAS: 13506-83-7), a bifunctional boronic acid derivative, has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its two boronic acid groups attached to a benzene ring, exhibits unique reactivity and binding properties, making it a valuable tool in drug discovery, sensor development, and materials science. Recent studies have explored its potential in targeted drug delivery, enzyme inhibition, and as a building block for functional materials, highlighting its broad utility in interdisciplinary research.

One of the most promising applications of Boronic acid,1,2-phenylenebis- (9CI) is in the development of protease inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a reversible inhibitor of serine proteases, which are implicated in various pathological conditions, including cancer and inflammatory diseases. The study revealed that the compound's ability to form stable boronate esters with the active-site serine residue enhances its inhibitory potency, offering a novel mechanism for therapeutic intervention. This finding opens new avenues for the design of boronic acid-based inhibitors with improved selectivity and pharmacokinetic properties.

In addition to its therapeutic potential, Boronic acid,1,2-phenylenebis- (9CI) has been employed in the development of advanced biosensors. A recent ACS Sensors publication (2024) highlighted its use in glucose sensing, where the compound's boronic acid groups selectively bind to diols, enabling the detection of glucose at physiologically relevant concentrations. The study reported a significant improvement in sensor stability and response time compared to traditional boronic acid-based sensors, underscoring the compound's advantages in diagnostic applications. This innovation holds promise for continuous glucose monitoring systems, particularly for diabetes management.

Material science has also benefited from the unique properties of Boronic acid,1,2-phenylenebis- (9CI). Researchers have utilized its ability to form dynamic covalent bonds to create self-healing polymers and responsive hydrogels. A 2023 Advanced Materials study described the synthesis of a boronic acid-based hydrogel that exhibits pH-responsive swelling behavior, making it suitable for controlled drug release applications. The hydrogel's reversible cross-linking via boronate ester formation allows for tunable mechanical properties and degradation rates, addressing key challenges in biomaterial design. These advancements highlight the compound's versatility beyond traditional pharmaceutical applications.

Despite these promising developments, challenges remain in the optimization of Boronic acid,1,2-phenylenebis- (9CI) for clinical and industrial use. Issues such as solubility, stability in physiological conditions, and potential off-target effects require further investigation. Ongoing research aims to address these limitations through structural modifications and formulation strategies. For instance, a 2024 Chemical Communications report proposed the use of nanoparticle carriers to enhance the delivery and bioavailability of boronic acid-based therapeutics, demonstrating improved efficacy in preclinical models. Such innovations are critical for translating laboratory findings into practical applications.

In conclusion, Boronic acid,1,2-phenylenebis- (9CI) (CAS: 13506-83-7) represents a multifaceted compound with significant potential in chemical biology and pharmaceutical research. Its applications span from drug discovery to biosensing and materials engineering, driven by its unique chemical properties. As research continues to uncover new functionalities and optimize existing ones, this compound is poised to play an increasingly important role in addressing complex biomedical challenges. Future studies should focus on overcoming current limitations and exploring novel applications to fully realize its potential in the field.

• 98-80-6(Phenylboronic acid)
• 4612-28-6(1,3-benzenediboronicacid)
• 654664-63-8(Triphenylen-2-ylboronic acid)
• 4612-26-4(1,4-Phenylenediboronic acid)
• 141981-64-8(2-Anthraceneboronic Acid)
• 32316-92-0(2-Naphthylboronic acid)
• 1188094-46-3(Phenanthren-3-ylboronic acid)
• 1188094-10-1(B-2-Phenanthrenyl-boronic acid)
• 215527-70-1(Phenylboronic Acid-d5)
• 89641-21-4(BTBA)